| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |